BPC-157 user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and do not prove that it works.

This page does not list users’ doses or sellers. Doses used in studies, with sources, and the calculator: BPC-157 dosage in studies.

Updated 15 Oct 2026 Data: 2,564 posts and comments read, 886 people Author: An AI model read and classified every account following written instructions

In short

Of 886 people, 578 (65%) said BPC-157 brought some benefit and 356 (40%) some harm.

We went through 1,064 public Reddit posts and a random sample of comments (1,500); the first-hand experiences of 886 users among them are compiled here. Method: Where the accounts come from and how we read them. Use of AI: AI disclosure.

Where the accounts come from and how we read them

Sources: the Reddit forums r/bpc_157 (827 accounts), r/Peptides (229) and r/Biohackers (60), plus a few other forums (9), 1 Oct 2025 to 9 Oct 2026. The posts were retrieved from a public Reddit archive; we listed those where the writer describes their own use, and read every one. 6,529 comments met the same criteria in the same period (from 1 Oct 2025 to 13 Oct 2026), and a random 1,500 of them were read. The sample was drawn with a fixed seed, so it can be repeated. A separate AI run classified 150 comments again without seeing the first classification, and the main fields matched: 144/150 (96%).

Classification: following written instructions, an AI model recorded for each account what it was used for, the body area, reported benefits, reported harms, time to the first change, length of use, whether other substances were used at the same time, and where it came from. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Left out: 34 posts from 26 Reddit accounts looked like marketing (for example the same "pro athlete story" with prices several times, or vendor praise). They are not in the numbers. With them included, 601/909 would report a benefit.

Whose accounts these are: 567 (64%) used it for a tendon, joint, muscle or back problem. 360 (41%) described an injected product and 112 (13%) an oral one. The figures describe the writers and are not a recommendation. 30 said they got it from a doctor, clinic or pharmacy, 66 from a grey-market seller, and 790 did not say. The products were not verified, so we do not know what people actually took.

What did users take BPC-157 for?

Most often shoulder, knee, back and elbow problems. For many the problem had lasted months or years, and physiotherapy, a cortisone shot or rest had not helped. Some used it to recover from surgery, some for gut symptoms.

Share = people / 886. Body area and injury type: share of the 567 people with a tendon, joint, muscle or back problem.
ReportedPeopleShare
What it was used for (n = 886)
Tendon, joint, muscle or back problem56764%
Stomach and gut8610%
General recovery or well-being394%
Skin and wounds313%
Mood, nerves or focus293%
Other313%
Body area (tendon, joint, muscle and back problems) (n = 567)
Shoulder16930%
Knee11120%
Back or neck8415%
Elbow7613%
Hip or groin438%
Ankle, foot or Achilles438%
Wrist, hand or fingers326%
Other (e.g. thigh, shin)519%
Type of injury or problem (n = 567)
Tendon (tendinitis or tear)16830%
Joint (arthritis, meniscus, disc)11721%
Recovery after surgery509%
Muscle366%
Ligament346%
Nerve254%
Bone142%
Not specified23942%

Most common reported benefits

Of 886 people. 578 (65%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Less pain22225%
Problem eased (not described further)17620%
Better movement or function13215%
Injury healed, faster than expected by their account11313%
Gut symptoms eased617%
Faster recovery from training587%
Less swelling or inflammation415%
Skin improved283%
Better sleep243%
Better mood or calmer222%
More energy152%
Other (e.g. reaction time, a nail, lab values)627%

Share = people / 886.

Most common reported harms and complaints

Of 886 people. 356 (40%) mentioned some harm; 36 said explicitly they had none.

ReportedPeopleShare
Emotional flatness or low mood546%
Tiredness or exhaustion526%
Anxiety, restlessness or panic485%
Insomnia or unusually vivid dreams455%
Gut symptoms (nausea, diarrhoea, gas)415%
Palpitations, fast heart rate or blood pressure change374%
Eye symptoms (blur, light sensitivity, eye pain)374%
Pain, stinging or a reaction at the injection site374%
The problem or old aches got worse283%
Headache253%
Tingling, numbness or sore skin233%
Skin symptoms (rash, itch, new changes)192%
Dizziness162%
Brain fog or memory problems101%
Lower sex drive or function91%
Feeling hot or sweating91%
Fainting4<1%
Other (e.g. a late period, swollen lymph nodes, aches, bruising)14016%

Share = people / 886.

Did BPC-157 help? Expectations and disappointments

688 people stated an outcome. Of them, 430 (63%) described a clear improvement, 107 (16%) a partial or short-lived one, 71 (10%) noticed no effect and 13 said it got worse.

Outcome in the writer’s own wordsPeopleShare
Clear improvement43063%
Partial or short-lived improvement10716%
No effect7110%
Cannot tell whether it was the substance436%
Too early to say243%
Got worse132%

Fast change. Of the 186 who said when they noticed the first change, 89 said within a week and 56 in 1-2 weeks. The accounts cannot tell whether that was the substance, placebo or natural recovery.

Pain gone, injury not necessarily. 16 said the effect faded during use or the symptoms returned after a break, and one described the pain going away while strength did not come back (quotes below).

Disappointments. 49 said outright they expected more. Most often it was a tendon, joint or back problem (for example shoulder, knee or elbow) where help did not come or stayed small; also gut symptoms, acne scars and trials stopped because of harms. The no-effect group also included long-standing disc and neck problems.

Not knowing what helped. 438 (49%) used TB-500 at the same time, often in a ready-made blend, and 268 other substances. Only 362 (41%) did not mention any other substance. 113 mentioned rehab at the same time, and some said themselves that they do not know whether it was the substance or time.

Posts vs. comments

The figures on this page combine two sets: all 374 people who described their own use in a post, and 512 people found only in comments. 6,529 comments met the criteria, and a random 1,500 of them were read, from the same period as the posts: from 1 Oct 2025 to 13 Oct 2026. Because only part of the comments was read, the combined shares are not an average of the whole discussion.

Comments reported benefit only clearly more often, and harms less often, than posts. Benefit only: 43% in posts and 57% in comments (difference +14 percentage points, 95% confidence interval +8 to +21). Some harm: 46% in posts and 35% in comments (difference -11 percentage points, 95% confidence interval -18 to -5).

A possible explanation, which we have not verified: people tend to write their own post when something goes wrong, while replies often say briefly that it worked. Neither group tells how often it really helps or harms, and the difference does not prove that it works.

Share = people / group n; number of people in brackets. Comments = people not already counted from posts. Difference = comments minus posts, from unrounded shares. A difference is clear when its 95% confidence interval does not include zero.
ReportedPosts (n = 374)Comments (n = 512)Difference, points (95% CI)Clear difference?
Benefit only43% (159)57% (291)+14 (+8, +21)Yes
Some harm46% (172)35% (177)-11 (-18, -5)Yes

How long did people use BPC-157?

513 of 886 people (58%) said how long they had been using it at the time of writing, or for the whole course. Where one person wrote several posts, the longest stated time counts. 312 (61%) had used it for a month or less, 103 (20%) for more than two months.

Stated length of usePeopleShare
Under 2 weeks15530%
2-4 weeks15731%
Over a month, up to 2 months9819%
Over 2 months10320%

First change. Of the 186 who said when they noticed the first benefit, 89 noticed it within a week, 56 in 1-2 weeks, 31 in 3-4 weeks and 10 only after more than a month.

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

What did people say about harms?

In many accounts the symptoms began in the first days or weeks. Some stopped because of them and said the symptoms went away within a few days. A few said symptoms lasted for weeks after stopping.

Recurring themes were anxiety, insomnia and emotional flatness. Of the 90 people reporting anxiety or flatness, 8 said they were also taking an SSRI antidepressant. In addition, 37 described eye symptoms. None of these links has been studied in humans. Harms known from research: What side effects does BPC-157 have?.

Single accounts also mentioned worrying events whose link to the substance is unknown: appendicitis, blood in the stool, chest pain with an irregular heartbeat, growth of fatty lumps (lipomas) and a recurrence of thyroid inflammation.

133 reported both a benefit and a harm. A few put it as: the benefit was real, but the harms cancelled it out.

About dosing

374 people (42%) mention amounts or ways of using it. We do not repeat them on this page and we give no dosing or how-to instructions. A safe dose is not known, and in Finland BPC-157 is classed as a medicine: Is BPC-157 legal in Finland and the EU?.

What can be concluded?

The accounts show why people are interested: many with long-standing pain say it helped when nothing else did. They also show what is worth studying: pain, function and recovery, and anxiety, sleep and emotional flatness as harms.

They do not prove that it works. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects in pain are large. The research and its evidence levels: evidence level at a glance. A placebo-controlled trial in hamstring injuries is recruiting: Future.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, partial help, no help and harms.

Another summary made with the same method: user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.